Correlation Between Dyne Therapeutics and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Foghorn Therapeutics, you can compare the effects of market volatilities on Dyne Therapeutics and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Foghorn Therapeutics.
Diversification Opportunities for Dyne Therapeutics and Foghorn Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dyne and Foghorn is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Dyne Therapeutics and Foghorn Therapeutics
Considering the 90-day investment horizon Dyne Therapeutics is expected to under-perform the Foghorn Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dyne Therapeutics is 1.0 times less risky than Foghorn Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Foghorn Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 760.00 in Foghorn Therapeutics on August 28, 2024 and sell it today you would lose (8.00) from holding Foghorn Therapeutics or give up 1.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyne Therapeutics vs. Foghorn Therapeutics
Performance |
| Timeline |
| Dyne Therapeutics |
| Foghorn Therapeutics |
Dyne Therapeutics and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyne Therapeutics and Foghorn Therapeutics
The main advantage of trading using opposite Dyne Therapeutics and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Dyne Therapeutics vs. Eliem Therapeutics | Dyne Therapeutics vs. Scpharmaceuticals | Dyne Therapeutics vs. Milestone Pharmaceuticals | Dyne Therapeutics vs. Seres Therapeutics |
| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |